Artículo

Toolkit to Examine Lifelike Language v.2.0: Optimizing Speech Biomarkers of Neurodegeneration

García, Adolfo Martín Icon; Ferrante, Franco Javier Icon; Pérez, Gonzalo Nicolas Icon; Ponferrada, Joaquín ; Sosa Welford, Alejandro ; Pelella, Nicolás ; Caccia, Ariel Matías ; Belloli, Laouen Mayal Louan Icon; Calcaterra, Cecilia ; González Santibáñez, Catalina ; Echegoyen, Raúl ; Cerrutti, Mariano Javier ; Jjohann, Fernando ; Hesse, Eugenia ; Carrillo, Facundo Icon

Otros responsables

Fecha

09/2024

Editorial

Karger

Revista

Dimentia And Geriatric Congnitive Disorders

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

1420-8008

eISSN

1421-9824

ISBN

Idioma

Inglés

Tipo del evento

Clasificación temática

Resumen

Introduction: The Toolkit to Examine Lifelike Language (TELL) is a web-based application providing speech biomarkers of neurodegeneration. After deployment of TELL v.1.0 in over 20 sites, we now introduce TELL v.2.0. Methods: First, we describe the app’s usability features, including functions for collecting and processing data onsite, offline, and via videoconference. Second, we summarize its clinical survey, tapping on relevant habits (e.g., smoking, sleep) alongside linguistic predictors of performance (language history, use, proficiency, and difficulties). Third, we detail TELL’s speech-based assessments, each combining strategic tasks and features capturing diagnostically relevant domains (motor function, semantic memory, episodic memory, and emotional processing). Fourth, we specify the app’s new data analysis, visualization, and download options. Finally, we list core challenges and opportunities for development. Results: Overall, TELL v.2.0 offers scalable, objective, and multidimensional insights for the field. Conclusion: Through its technical and scientific breakthroughs, this tool can enhance disease detection, phenotyping, and monitoring.

Colecciones

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa